arrow
A

Andrea Sbrana

University of Pisa
H指数:16
被引数:983

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

THE ITALIAN MAURIS PHASE IIIB TRIAL OF ATEZOLIZUMAB PLUS CARBOPLATIN AND ETOPOSIDE FOR PATIENTS WITH NEWLY DIAGNOSED EXTENSIVE-STAGE SMALL CELL LUNG CANCER: 3-YEAR END-OF-STUDY RESULTS

意大利MAURIS 3期B研究:阿替利珠单抗联合卡铂和依托泊苷治疗新诊断广泛期小细胞肺癌的3年研究结束结果

2025-07-090
OAAI
Efficacy and Safety of Chemotherapy after Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer

晚期非小细胞肺癌患者免疫治疗后化疗的疗效和安全性

2024-06-212
OAAI
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial
2022-09-157
OAAI
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis

新型冠状病毒肺炎疫苗在癌症患者中的安全性和耐受性: 单中心回顾性分析

2022-06-021
OAAI
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)
2021-06-0821
OAAI
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)
2021-05-1851
OAAI
Management of Thyrotoxicosis Induced by PD1 or PD-L1 Blockade

PD1或PD-L1阻滞引起的甲状腺毒症的管理

2021-05-155
OAAI
Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients

对去势抵抗性前列腺癌患者的镭223和其他延长生命的药物进行测序

2021-01-290
PRE
Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study

在大型前瞻性真实世界队列中,醋酸阿比曲酮联合泼尼松在未接受化疗的转移性去势抵抗性前列腺癌患者中的有效性: ABItude研究

2020-10-297
OAAI